z-logo
Premium
Perturbations in paracrine control of the circulation: Role of the endothelial‐derived vasomediators, endothelin‐1 and nitric oxide
Author(s) -
Mawji Imtiaz A.,
Marsden Philip A.
Publication year - 2002
Publication title -
microscopy research and technique
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 118
eISSN - 1097-0029
pISSN - 1059-910X
DOI - 10.1002/jemt.10242
Subject(s) - enos , nitric oxide , paracrine signalling , endothelin 1 , messenger rna , microbiology and biotechnology , biology , endothelin receptor , nitric oxide synthase , nitric oxide synthase type iii , endothelium , chemistry , gene , endocrinology , biochemistry , receptor
Central to the control of vascular resistance in the systemic and pulmonary circulation and at the solid organ level is the function of the endothelial‐derived vasomediators, endothelin‐1 (ET‐1) and nitric oxide. Regulation of steady‐state levels of ET‐1 and endothelial nitric oxide synthase (eNOS) mRNAs represents an early and influential step in their biosynthesis and is highly responsive to exogenous stimuli. ET‐1 is expressed from a rapidly inducible promoter to generate a highly labile mRNA. Conversely, the eNOS promoter generates a constitutive level of a very stable mRNA and utilizes posttranscriptional mechanisms to modulate mRNA expression. The response of these genes in models of cellular activation commonly reflects a reciprocal pattern of regulation, namely, transcriptional induction of ET‐1 and destabilization of the eNOS mRNA. Elucidating the mechanisms influencing ET‐1 and eNOS mRNA is providing novel insight into endothelial gene regulation and providing opportunities for future therapeutic strategies. Microsc. Res. Tech. 60:46–58, 2003. © 2002 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here